We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Eli Lilly & Co on Tuesday said it expects to report lower fourth quarter revenue than the bottom of a range it had pr ...
Popular diabetes and obesity drugs by Novo Nordisk AS and Eli Lilly & Co could also help to protect the kidneys, a ne ...
Eli Lilly & Co on Wednesday reported strong revenue growth in the third quarter and a return to profit, as it develop ...
Eli Lilly & Co on Monday announced it has appointed Lucas Montarce as chief financial officer with immediate effect. ...
Eli Lilly & Co on Thursday raised annual guidance once again, as it reported double-digit growth in the second quarte ...
Patients taking Eli Lilly & Co's new drug Mounjaro achieved significantly greater weight loss than those on Novo Nord ...
Alphabet Inc on Wednesday said Anat Ashkenazi will become the company's new chief financial officer from the end of J ...
Eli Lilly & Co announced on Wednesday that it has come to an agreement with Totality Medispa over the latter's claim ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 81.83 | 81.83 | 81.83 | 740 | 81.83 | DE |
4 | 0 | 0 | 81.83 | 81.83 | 81.83 | 494 | 81.83 | DE |
12 | 0 | 0 | 81.83 | 81.83 | 81.83 | 864 | 81.83 | DE |
26 | 0 | 0 | 81.83 | 81.83 | 81.83 | 839 | 81.83 | DE |
52 | 0 | 0 | 81.83 | 81.83 | 81.83 | 715 | 81.83 | DE |
156 | 0 | 0 | 81.83 | 81.83 | 81.83 | 319 | 81.83 | DE |
260 | 0 | 0 | 81.83 | 81.83 | 81.83 | 226 | 81.83 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions